Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Synthetic Biologics Inc (SYN)

0.485   0.008 (1.66%) 09-29 10:24
Open: 0.4828 Pre. Close: 0.4771
High: 0.488 Low: 0.4737
Volume: 24,741 Market Cap: 9M
Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. The company is headquartered in Rockville, Maryland and currently employs 13 full-time employees. The firm is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The firm's lead product candidates in Phase II development are SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). Its other product candidates include SYN-007, SYN-006, SYN-005, SYN-200 and SYN-020. The firm is also developing preclinical-stage monoclonal antibody therapies for the prevention and treatment of pertussis, and discovery-stage biotherapeutics for the treatment of phenylketonuria (PKU).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.481 - 0.483 0.483 - 0.484
Low: 0.445 - 0.447 0.447 - 0.449
Close: 0.477 - 0.48 0.48 - 0.483

Technical analysis

as of: 2020-09-29 10:16:30 AM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.67     One year: 0.79
Support: Support1: 0.41    Support2: 0.34
Resistance: Resistance1: 0.58    Resistance2: 0.68
Pivot: 0.48
Moving Average: MA(5): 0.47     MA(20): 0.51
MA(100): 0.49     MA(250): 0.45
MACD: MACD(12,26): -0.02     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 38.41     %D(3): 27.40
RSI: RSI(14): 44.77
52-week: High: 0.75  Low: 0.25  Change(%): 12.0
Average Vol(K): 3-Month: 62688  10-Days: 26240

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
SYN has closed above bottom band by 47.4%. Bollinger Bands are 54.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to SYN's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 24 Sep 2020
Will Short Term Positive News Increase The Share Price Of Synthetic Biologics, Inc. (SYN)? - Invest Million

Mon, 14 Sep 2020
Roll up the Sleeves! When the bell rang at previous close Synthetic Biologics Inc. (SYN) was up 2.15% - The InvestChronicle

Fri, 04 Sep 2020
Synthetic Biologics, Inc. (NYSE:SYN) Stock Jumped 10.99% Year-To-Date, What Analysts Expect Next? - Marketing Sentinel

Thu, 03 Sep 2020
Synthetic Biologics Inc. (SYN) Plunges 9.45% on September 03 -

Tue, 01 Sep 2020
Synthetic Biologics, Inc. (NYSE:SYN) Is a Buzzing Hot Stock - Stocks Register

Tue, 01 Sep 2020
Synthetic Biologics Inc. (SYN) is heading in the right direction with an average volume of $603.48K - News Daemon

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18
Shares Float (M) 18
% Held by Insiders 0.13
% Held by Institutions 8.72
Shares Short (K) 20
Shares Short P. Month (K) 6

Stock Financials

EPS -0.925
EPS Est This Year -0.170
EPS Est Next Year -0.250
Book Value (p.s.) -0.290
Profit Margin
Operating Margin
Return on Assets (ttm) -49.1
Return on Equity (ttm) -93.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.815
Qtrly Earnings Growth
Operating Cash Flow (M) -15
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -0.52
PEG Ratio
Price to Book value -1.66
Price to Sales
Price to Cash Flow -0.60

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.